TEHRAN, Iran, Sept. 14
Trend:
A knowledge-based company in Iran succeeded to domestically manufacture special medications used during organ transplantations, Trend reports via IRNA.
The amount of saved funds amounted to annual $20 million, said the company's CEO Hossein Salami.
"The 'Iminoral Capsule' made by our company is prescribed to patients who had a transplant. This treatment is used to prevent organ rejection, following the transplant," he said.
“The annual production and sales value of this product in three doses of 25, 50 and 100 mg is worth over $14 million,” said Salami. “This medicine is 40 percent cheaper than similar foreign analogues."
He added that following several experiments, the high quality of 'Iminoral Capsule' was approved by local monitoring bodies.
Salami also praised the efforts of the company's young specialists.
"The company, using its biotechnology and equipment, intends to manufacture at least two new products, which are expected to go into mass production next year," he said.
Salami pointed to commitments of the Vice President for Science and Technology and the Innovation and Prosperity Fund to support and provide the necessary facilities for the development of production lines for the company.